Abstract
Marilyn L. Moy, Merilee Teylan, Valery A. Danilack, David R. Gagnon
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global burden of COPD: risk factors, prevalence, and future trends
10.1016/s0140-6736(07)61380-4 · 2007
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
10.1164/rccm.200703-456so · 2007
Susceptibility to exacerbation in chronic obstructive pulmonary disease
10.1056/nejmoa0909883 · 2010
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)
10.1164/ajrccm.154.4.8887592 · 1996
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
10.1164/ajrccm.157.5.9709032 · 1998
The costs of treating COPD in the United States
10.1378/chest.119.2.344 · 2001
Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease
10.1164/ajrccm.159.1.9803117 · 1999
Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study
10.1164/ajrccm.164.6.2006012 · 2001
Risk indexes for exacerbations and hospitalizations due to COPD
10.1378/chest.06-1316 · 2007
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
10.1183/09031936.00194610 · 2012
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
10.1056/nejmoa021322 · 2004
Prediction of risk of COPD exacerbations by the BODE index
10.1016/j.rmed.2008.10.004 · 2009
BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease
10.1097/maj.0b013e3181bb8111 · 2010
Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?
10.2174/1389450111314020005 · 2013
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study
10.1136/thx.2006.060145 · 2006
Prognostic value of the objective measurement of daily physical activity in patients with COPD
10.1378/chest.11-2014 · 2012
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
10.1136/thx.2003.019588 · 2004
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
10.1183/09031936.06.00109605 · 2006
Daily step count predicts acute exacerbations in a US cohort with COPD
10.1371/journal.pone.0060400 · 2013
Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study
10.1378/chest.10-2521 · 2011
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype
10.1371/journal.pone.0037483 · 2012
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease
10.1164/rccm.200605-713oc · 2007
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
10.1136/thx.2006.059808 · 2006
Daily step counts in a US cohort with COPD
10.1016/j.rmed.2012.03.016 · 2012
Standardisation of spirometry
10.1183/09031936.05.00034805 · 2005
ATS statement: guidelines for the six-minute walk test
10.1164/ajrccm.166.1.at1102 · 2002
Evaluation of clinical methods for rating dyspnea
10.1378/chest.93.3.580 · 1988
A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire
10.1164/ajrccm/145.6.1321 · 1992
Azithromycin for prevention of exacerbations of COPD
10.1056/nejmoa1104623 · 2011
Best practices for using physical activity monitors in population-based research
10.1249/mss.0b013e3182399e5b · 2012
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease
10.1164/rccm.201110-1792oc · 2012
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials
10.1136/thx.2007.082636 · 2008
Spirometric reference values from a sample of the general U.S. population
10.1164/ajrccm.159.1.9712108 · 1999
Daily step count is associated with plasma CRP and IL-6 in a US cohort with COPD
Kept as external metadata until matched
How many steps are enough to avoid severe physical inactivity in patients with chronic obstructive pulmonary disease?
10.1111/j.1440-1843.2012.02207.x · 2012
A pilot study of an internet walking program and pedometer in COPD
10.1016/j.rmed.2012.06.013 · 2012
Reasons persons with COPD do not walk and relationship with daily step count
Kept as external metadata until matched
Inflammatory changes, recovery and recurrence at COPD exacerbation
10.1183/09031936.00092506 · 2007
No additional external references are available.